Contact Us

Resources

Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast Growing CDMOs to Watch

Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast Growing CDMOs to Watch

,

Read Pharma Manufacturing's feature article entitled "Built to Thrive: Three CDMOs that set themselves up to flourish" Published on February 7, 2023 Thank you Pharma Manufacturing and author Karen Longhauser Pharma Manufacturing's feature article positions Bora as one of three fast growing CDMOs to watch. In their interview with Bora CEO, Bobby Sheng, the author acknowledges Bora's values...

read more

Bora Pharmaceuticals Featured in Pharma Intelligence Generic Bulletin

Bora Pharmaceuticals is mentioned as "the largest pharmaceutical group by volume in Taiwan" in 2022 after completing the company's "landmark acquisition" of TWi Pharmaceuticals. Published in the online version of Generics Bulletin. https://generics.pharmaintelligence.informa.com/GB152440/Standalone-Sandoz-And-Biocons-Biosimilars-2022s-Biggest-Deals Thank you Pharma Intelligence andAuthor Dean...

read more
Bora Pharmaceuticals Featured in Fierce Pharma – Bora’s Quest to Join Ranks of Top CDMOs

Bora Pharmaceuticals Featured in Fierce Pharma – Bora’s Quest to Join Ranks of Top CDMOs

,

Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled "After Bora's biologics debut, CEO outlines quest to join ranks of top CDMOs". Published on November 10, 2022Thank you Fierce Pharma and author Fraiser Kansteiner Bora's focus on customer partnership is key to Bora's acquisition strategy. Bora's recent addition of biologics offerings with acquisition of Eden...

read more
Bora expands its CMDO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Bora expands its CMDO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

Bora establishes a lead position in Taiwan's CDMO sector TAIWAN - Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic drugs. Acquiring TWi Pharmaceuticals adds two manufacturing facilities and will...

read more
Skip to content